AB Science announces the initiation of coverage of its stock by Maxim Group with a target price of EUR 4.0 per share
Globenewswire· 2025-12-18 18:17
PRESS RELEASE AB SCIENCE ANNOUNCES THE INITIATION OF COVERAGE OF ITS STOCK BY MAXIM GROUP WITH A TARGET PRICE OF EUR 4.0 PER SHARE Paris, December 18, 2025, 7.15pm CET AB Science SA (Euronext - FR0010557264 - AB) announces the initiation of coverage of its stock by Maxim Group, an independent US-based full-service investment bank, securities and wealth management firm. Maxim Group began covering the stock with a study entitled “Mastering Mast Cell Inhibition for Neurodegenerative Diseases Starting with ALS” ...
Kering announces the staged acquisition of Raselli Franco Group, a leading jewelry manufacturer
Globenewswire· 2025-12-18 18:17
Press release - Staged acquisition of Raselli Franco Group - 18 12 2025 PRESS RELEASE December 18, 2025 KERING ANNOUNCES THE STAGED ACQUISITION OF RASELLI FRANCO GROUP, A LEADING JEWELRY MANUFACTURER One of the largest global independent luxury jewelry manufacturers in Europe Initial 20% stake, with pathway to full ownership by 2032 A major step for Kering, creating a sizeable platform for future growth in jewelry Kering is pleased to announce the signing of an agreement to acquire Raselli Franco Group, a ...
Is Target Stock a Buy or Sell at Its Current Valuation?
ZACKS· 2025-12-18 18:16
Key Takeaways TGT trades 32% below its 52-week high and at a sharp discount to peers despite recent share-price strength.TGT's digital ecosystem is expanding, with same-day services, Target Plus and Roundel driving growth.TGT cut its FY25 EPS view, as weak discretionary demand and rising debt will likely hurt near-term results.Target Corporation (TGT) is currently trading at a forward 12-month price-to-earnings (P/E) multiple of 12.84X, which positions it at a discount compared with the Zacks Retail - Disco ...
Hancock Whitney Hits 52-Week High: Should You Buy the Stock Now?
ZACKS· 2025-12-18 18:16
Key Takeaways HWC shares hit a 52-week high of $67.10, gaining 23.2% over six months and beating the industry.Hancock Whitney's revenues saw a 3.5% CAGR over five years, supported by expansion plans and loan growth.HWC's expanding NIM, solid balance sheet, dividend hikes and new buyback plan support shareholder value.Shares of Hancock Whitney Corp. (HWC) touched a new 52-week high of $67.10 per share in yesterday’s trading session to finally close at $66.05. Over the last six months, the HWC stock has gaine ...
From biotech to defense, here are 10 top stock picks for 2026 from UBS
Yahoo Finance· 2025-12-18 18:15
Fabrice COFFRINI / AFP via Getty Images UBS gave its highest conviction calls for 2026, laying out its top stock picks across sectors. The bank is bullish on a wide variety of companies spanning several high-growth sectors. A few of its top stocks for 2026 include Acadia Pharmaceuticals and Alliant Energy. If you're making your list of stocks to watch in the new year, UBS has a list of its highest conviction stocks for 2026 that could offer some insight. The bank released its list of top picks fo ...
BROAD ARROW EXCEEDS $624 MILLION IN TOTAL TRANSACTIONS ACROSS AUCTIONS, PRIVATE SALES, AND FINANCING IN 2025
Globenewswire· 2025-12-18 18:15
2025 RESULTS SIGNIFY 97 PERCENT YEAR-OVER-YEAR GROWTH IN TOTAL TRANSACTION VALUE FOR BROAD ARROW, A HAGERTY COMPANY, FOUNDED IN 2021 1959 Ferrari 250 GT LWB California Spider Competizione, Broad Arrow’s top sale of 2025, sold at The Amelia Auction in March 2025 at The Ritz-Carlton Amelia Island Credit – Andrew Miterko/Courtesy of Broad Arrow The 1995 McLaren F1 sold via Broad Arrow Private Sales in 2025 Credit – Tom Nisco/Courtesy of Broad Arrow Grosse Pointe, Michigan, Dec. 18, 2025 (GLOBE NEWSWIRE ...
Capricor Therapeutics, Inc. (CAPR): A Bear Case Theory
Yahoo Finance· 2025-12-18 18:14
We came across a bearish thesis on Capricor Therapeutics, Inc. on Alpha Talon Investment Research’s Substack by AT Investment Research. In this article, we will summarize the bulls’ thesis on CAPR. Capricor Therapeutics, Inc.'s share was trading at $26.55 as of December 15th. Telix Pharma (TLX) Makes Progress With New Study Capricor Therapeutics, Inc., a clinical-stage biotechnology company, develops transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD) and oth ...
McDonald’s Corporation (MCD): A Bull Case Theory
Yahoo Finance· 2025-12-18 18:14
We came across a bullish thesis on McDonald’s Corporation on wallstreetbets subreddit by nskidder. In this article, we will summarize the bulls’ thesis on MCD. McDonald’s Corporation's share was trading at $318.73 as of December 15th. MCD’s trailing and forward P/E were 27.02 and 23.92 respectively according to Yahoo Finance. People Love McDonald’s Corporation (MCD) Because Of Value, Says Jim Cramer McDonald's Corporation owns, operates, and franchises restaurants under the McDonald's brand in the United ...
Moderna, Inc. (MRNA): A Bull Case Theory
Yahoo Finance· 2025-12-18 18:14
We came across a bullish thesis on Moderna, Inc. on Alpha Talon Investment Research’s Substack by AT Investment Research. In this article, we will summarize the bulls’ thesis on MRNA. Moderna, Inc.'s share was trading at $29.92 as of December 15th. MRNA’s trailing P/E was 7.06 according to Yahoo Finance. Is Ultragenyx Pharmaceutical Inc. (RARE) One of the Best Biotech Stocks to Buy According to Wall Street Analysts? Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United St ...
Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory
Yahoo Finance· 2025-12-18 18:13
We came across a bullish thesis on Sarepta Therapeutics, Inc. on Alpha Talon Investment Research’s Substack by AT Investment Research. In this article, we will summarize the bulls’ thesis on SRPT. Sarepta Therapeutics, Inc.'s share was trading at $21.55 as of December 15th. SRPT’s trailing and forward P/E were 169.47 and 17.39 respectively according to Yahoo Finance. Pixabay/Public Domain Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development o ...